Sign in

CIK 0001840439

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Biomea Fusion, Inc.

Sign in to watch
Ticker
BMEA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 650-980-9099
Business address
1599 INDUSTRIAL ROAD, SAN CARLOS, CA, 94070
  1. 4 Open-market sale 10% owner sold 34,658 shares at $11.76 ($407,578)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Derivatives Options or other derivatives
  8. 4 Other disposition 10% owner disposed of 4,365,342 shares (other)
  9. 4 Grant or award Chief Financial Officer acquired 3,307 shares (grant or award)
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market buy Chief Financial Officer bought 10,000 shares at $8.68 ($86,767)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market buy 10% owner bought 34,658 shares at $10.96 ($379,852)
  16. 4 Open-market buy Director bought 34,658 shares at $10.96 ($379,852)
  17. 4 Open-market buy President & COO bought 24,000 shares at $13.20 ($316,872)
  18. 4 Open-market buy CEO bought 24,000 shares at $13.20 ($316,872)
  19. 4 Open-market buy President & COO bought 204,470 shares at an average $16.15 ($3,301,795)
  20. 4 Open-market buy CEO bought 204,470 shares at an average $16.15 ($3,301,795)

Page 4 of 5 · 98 filings